A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human alpha(?) integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer

DSpace Repository

A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human alpha(?) integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer

Author: Heidenreich, A.; Rawal, S. K.; Szkarlat, K.; Bogdanova, N.; Dirix, L.; Stenzl, A.; Welslau, M.; Wang, G.; Dawkins, F.; de Boer, C. J.; Schrijvers, D.
Tübinger Autor(en):
Stenzl, Arnulf
Published in: Annals of Oncology (2013), Bd. 24, H. 2, S. 329-336
Verlagsangabe: Oxford Univ Press
Language: English
Full text: http://dx.doi.org/10.1093/annonc/mds505
ISSN: 0923-7534
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)